Martin has been an investment professional at Patricia Industries Nordic since 2015. He joined Investor AB in 2012 and has since then worked with a broad set of companies and industries, albeit with emphasis on technology, telecom and medtech.
Martin currently works with the European portfolio of financial investments held by Patricia Industries, with 3Scandinavia, Atlas Antibodies and with new investments. He also serves on the board in Atlas Antibodies. During 2017, Martin was on one-year secondment to Mölnlycke, working within corporate strategy and business development.
Martin holds an M.Sc. in Accounting and Financial Management from the Stockholm School of Economics, partly completed at National University of Singapore and partly at Cornell University, New York. During his studies, Martin worked at Carnegie Investment Bank, PwC, Nordea Markets, and Kantar Millward Brown.